Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia

NCT05330364 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Chidamide
DRUG: Cladribine

Sponsor

Ge Zheng